Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Ekso Bionics Holdings, Inc. (EKSO) had Revenue of $12.80M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$12.80M
Net Income	$-11.70M
Cost of Goods Sold	$5.95M
Gross Profit	$6.84M
Operating Expenses	$26.12M
Operating Income	$-13.33M
Non-Operating Income/Expense	$1.63M
Pre-Tax Income	$-11.70M
Normalized Pre-Tax Income	$-11.70M
Income after Taxes	$-11.70M
Income from Continuous Operations	$-11.70M
Consolidated Net Income/Loss	$-11.70M
Normalized Income after Taxes	$-11.70M
EBIT	$-13.33M
EBITDA	$-11.75M
Weighted-Average Shares Outstanding (Basic)	2.43M
Weighted-Average Shares Outstanding (Diluted)	2.43M
Earnings per Share (EPS) (Basic)	$-4.91
Earnings per Share (EPS) (Diluted)	$-4.91
Balance Sheet Financials
Current Assets	$14.05M
Property, Plant, and Equipment	$1.29M
Long-Term Assets	$6.06M
Total Assets	$20.11M
Current Liabilities	$8.64M
Long-Term Debt	$0.80M
Long-Term Liabilities	$2.45M
Total Liabilities	$11.08M
Common Equity	$9.03M
Tangible Shareholders Equity	$5.10M
Shareholders Equity	$9.03M
Common Shares Outstanding	3.56M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-11.80M
Cash Flow from Investing Activities	$-0.19M
Cash Flow from Financial Activities	$6.63M
Beginning Cash	$6.49M
End Cash	$1.17M
Increase/Decrease in Cash	$-5.32M
Stock-Based Compensation	$1.47M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.63
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.08
Debt to Equity Ratio	0.45
Gross Margin	53.48%
Operating Margin	-104.12%
EBIT Margin	-104.12%
EBITDA Margin	-91.83%
Pre-Tax Profit Margin	-91.37%
Profit Margin	-91.37%
Free Cash Flow	$-11.99M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.64
Inventory Turnover	1.23
Receiveable Turnover	1.75
Days Sales in Receivables	208.41
Return on Equity	-129.56%
Return on Tangible Equity	-229.49%
Return on Assets	-58.15%
Return on Investments	-119.03%
Book Value Per Share	$2.54
Free Cash Flow per Share	$-4.94
Operating Cash Flow per Share	$-4.86

Data from Zacks Investment Research, Inc.